A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation  by Woollard, J.R. et al.
A mouse model of autosomal recessive polycystic
kidney disease with biliary duct and proximal tubule
dilatation
JR Woollard1, R Punyashtiti1, S Richardson1, TV Masyuk2, S Whelan1, BQ Huang2, DJ Lager3,
J vanDeursen4, VE Torres1, VH Gattone5, NF LaRusso2, PC Harris1 and CJ Ward1
1Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; 2Division of Gastroenterology
and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; 3Department of Pathology, Mayo Clinic College of
Medicine, Rochester, Minnesota, USA; 4Department of Biochemistry/Molecular Biology, Mayo Clinic College of Medicine, Rochester,
Minnesota, USA and 5Department of Anatomy and Cell Biology, Indiana School of Medicine, Indianapolis, Indiana, USA
Autosomal recessive polycystic kidney disease (ARPKD) is
caused by mutations in the polycystic kidney and hepatic
disease (PKHD1) gene encoding the protein fibrocystin/
polyductin. The aim of our study was to produce a mouse
model of ARPKD in which there was no functional fibrocystin/
polyductin to study the pathophysiology of cystic and
fibrocystic disease in renal and non-renal tissues. Exon 2 of
the gene was deleted and replaced with a neomycin
resistance cassette flanked by loxP sites, which could be
subsequently removed by Cre-lox recombinase. Homozygous
Pkhd1del2/del2 mice were viable, fertile and exhibited hepatic,
pancreatic, and renal abnormalities. The biliary phenotype
displayed progressive bile duct dilatation, resulting in grossly
cystic and fibrotic livers in all animals. The primary cilia in the
bile ducts of these mutant mice had structural abnormalities
and were significantly shorter than those of wild-type (WT)
animals. The Pkhd1del2/del2 mice often developed pancreatic
cysts and some exhibited gross pancreatic enlargement. In
the kidneys of affected female mice, there was tubular
dilatation of the S3 segment of the proximal tubule (PT)
starting at about 9 months of age, whereas male mice had
normal kidneys up to 18 months of age. Inbreeding the
mutation onto BALBc/J or C57BL/6J background mice
resulted in females developing PT dilatation by 3 months of
age. These inbred mice will be useful resources for studying
the mechanisms underlying the pathogenesis of ARPKD.
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Mutations in the polycystic kidney and hepatic disease
(PKHD1) gene are responsible for autosomal recessive
polycystic kidney disease (ARPKD) (MIM 263200).1–3
ARPKD is characterized by various combinations of bilateral
renal cystic disease and congenital hepatic fibrosis with or
without non-obstructive intrahepatic bile duct dilatation
(Caroli disease). Most patients present in utero or at birth
with marked renal enlargement and biliary dysgenesis on
liver biopsy, whereas a minority of patients present as older
children, teenagers, or adults, usually with manifestations of
portal hypertension or cholangitis and renal involvement
ranging from non-existent to medullary ectasia of the
collecting ducts (CD) and cystic disease. Severe ARPKD
develops in utero, starting with the dilatation of both
proximal tubules (PT) and CD.4 After 34 weeks of fetal age
the CD dilatation predominates and is responsible for the
massive enlargement of the kidney. The PT dilatation appears
to be an early and transient feature of both ARPKD and
multiple animal models such as the orpk,5 cpk,6 and bpk7
mice.
PKHD1 is a large (67 exon) gene extending overB0.5 Mb
of human chromosome 6p12 that encodes an mRNA of
16 kb.8,9 The protein product, fibrocystin (FC), is 4074 amino
acids long and is predicted to be a large type 1 membrane
protein that has been shown to be present in the basal body
and primary cilium.10–13 The cilium/centriolar localization
makes it a member of a growing list of ciliary proteins
involved in cystic kidney disease, which include: polycystin-1
and -2, cystin, polaris/IFT88,14 and inversin,15,16 as well as a
range of other proteins associated with nephronophthisis and
Bardet–Biedl syndrome.17
The large size of the gene makes it a significant mutational
target and a wide range of mainly private mutations have
been described. Phenotype/genotype correlations indicate
that two truncating mutations are associated with the severe,
lethal phenotype, whereas one or two missense changes are
often associated with milder disease.18 This phenotypic
spread is also reflected in the available animal models of
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ARPKD with Pkhd1 mutations.19,20 The polycystic kidney
(PCK) rat with a frame-shifting exon 36 skipping mutation8
and the ex40 mouse with an in-frame deletion of exon 4020
develop liver cysts and fibrosis. In the kidney the PCK rat has
distal tubule and CD cysts,19 but the ex40 mouse has been
reported to have a histologically normal kidney up to 14
months of age.20
The ex40 mouse has been suggested to be a hypomorphic
allele with an in-frame deletion, and because the PCK rat has
a splicing change, it is possible that it could also produce a
shortened but functional protein, leading to a hypomorphic
phenotype. To overcome this potential problem, we targeted
the first coding exon, exon 2, which contains the start
methionine and the signal peptide of FC.
Here we report a mouse model with an ARPKD gene
mutation, which develops PT dilatation in the adult female
mouse without the transition to CD dilatation. This animal
develops liver disease similar to that observed in Caroli
disease and so may be a valuable resource for studying the
development of fibrocystic liver disease as well as the PT and
CD disease transition in the development of human ARPKD.
RESULTS
Targeting of the murine Pkhd1 gene
We targeted exon 2 of the mouse Pkhd1 gene with a
conventional LoxP flanked phosphoglycerate kinase (PGK)
neomycin cassette (Figure 1a) and screened by Southern
blotting (Figure 1b). Mice were derived from three separate
embryonic stem cell clones to generate Pkhd1neo2 animals and
these were in turn crossed to mouse mammary tumor virus-
Cre animals to allow for the germline removal of the PGK
neomycin cassette yielding the Pkhd1del2 allele.21 Wild type
(WT), Pkhd1neo2, and Pkhd1del2 were easily distinguished by
polymerase chain reaction (PCR) (Figure 1b). 50 RACE and
directed reverse transcription-PCR showed that there was a
transcript produced from the mutant allele, which skips exon
2 using the splice donor of exon 1 and the splice acceptor of
exon 3 in both Pkhd1neo2 and Pkhd1del2 homozygous mice
(Figure 1c).
Phenotype of the Pkhd1 knockout
No significant phenotypic differences were seen between the
animals derived from the three different clones, with or
without the neo cassette. The number and genotypes of the
mice used in this study are shown in Table 1. Mice were born
in normal Mendelian ratios (28 WT, 59 Pkhd1neo2/þ , 17
Pkhd1neo2/neo2 w2¼ 4.2, 2 d.f., P¼ 0.121). Pkhd1del2/þ ani-
mals had no phenotype up to 18 months of age in line with
the observation that ARPKD carriers are healthy.
Mice harboring the homozygous Pkhd1neo2 or Pkhd1del2
mutation were fertile. The initial Pkhd1del2/del2 mice had a
significant and variable 129Sve contribution and are referred
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Figure 1 | A schematic diagram of the knockout construct used in this study. (a)The neomycin cassette was positioned in an orientation
opposite to the Pkhd1 promoter replacing exon 2. Exon 2 contains the start methionine and the signal peptide. The neomycin cassette is
flanked by two LoxP sites so that it can be removed by the expression of Cre recombinase. (b) Southern blot analysis shows the expected DNA
fragments using the 50 and 30 probes. The left panel shows genomic DNA cut with Spe-1 with bands of the expected size 9 and 17 Kb;
the middle panel shows genomic DNA cut with HindIII with bands of 17 and 13.6 Kb. The right hand panel is a 1.5% agarose gel with PCR
products derived from primers F1 and R1/R2. The WT and is 1028 bp, the LoxP deleted allele is 900 bp and the neomycin allele is 794 bp.
(c) Reverse transcription-PCR data confirming that exon 2 is skipped in both kidney and liver of homozygous mice.
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to as outbred. We inbred these animals onto BALBc/J and
C57BL/6J backgrounds to generation F10, referred to as
inbred.
Liver and pancreatic phenotypes of Pkhd1 knockouts
Pkhd1del2/del2 mice developed fibrocystic disease of the liver
so that by 9 months there was a significant increase in the
liver body weight ratio (Figure 2a), which was maintained
out to 18 months of age. Often the livers were massively
enlarged occupying much of the abdominal cavity and were
macroscopically cystic (Figure 3a).
Histologically, biliary dilatation was observed at 1 month
of age in 100% of outbred Pkhd1del2/del2 mice (Figure 3b) and
it worsened with time (Figure 3c–g) so that by 12–15 months
most of the liver was replaced by cysts. At early stages, bile
duct proliferation was evident in the portal areas with
primitive tortuous bile ducts and reactive stroma. By 6–9
months progressive portal fibrosis was evident (Figure 3e and g).
In 11 mice, the pancreas was enlarged and markedly cystic.
Up to 20 ml of cystic fluid could be aspirated from these
pancreas (Figure 3h and Table 2). Dilated pancreatic ducts
and cysts were lined with a hyperplastic columnar epithelium
surrounded by a fibrotic stroma (Figure 3i). Microscopic
cysts were detected in 44 of 92 Pkhd1del2/del2 pancreas
examined (Figure 3j and k) when compared to the WT
(Figure 3l). Duct walls were thickened and the ducts were
dilated and lined with hyperplastic columnar epithelium.
Kidney phenotype
The kidneys of the Pkhd1del2/del2 mice appeared normal until
approximately 9 months of age, when outbred females began
to develop cystic dilatation in the outer stripe of the outer
medulla and inner cortex (Figure 4). To determine the
tubular segment dilated, kidneys were stained with Lotus
tetragonolobus agglutinin (LTA) for the PT and Dolichos
biflous agglutinin (DBA) for the CD as well as Calbindin
D28k for the distal tubule and Tamm Horsfall protein for the
thick ascending limb of the loop of Henle. The CD and the
distal tubule were never dilated in the 159 Pkhd1del2/del2
outbred animals.
Tubular dilatation was always restricted to LTA-positive
tubule segments in females analyzed at 9–15 months (Figures 5,
6b, e, and h). Outbred male kidneys were not affected even at
18 months (Figure 4a–c, Table 3). Female outbred animals
exhibited an increase in PT dilation from 9 to 12 months in
both the WT and Pkhd1del2/del2 (Table 4). The increase in the
WT PT was small yet significant (2.5 mm, Po0.05), whereas
the increase in the Pkhd1del2/del2 PTs was much greater
(11.2 mm; Po0.0005). On inbreeding on a BALBc/J or
C57BL/6J background, the female PTs become dilated by
3 months of age (n¼ 3) BALBc/J and (n¼ 3) C57BL/6J
(Figure 6b, e, and h). Kidney body mass ratios did not
significantly differ from WT animals (Figure 2b).
In the older Pkhd1del2/del2 animals (15 month), the brush
border of the dilated tubules was attenuated and in extreme
cases was lost as assessed by periodic acid shift (data not
shown). To assess the state of brush border in non-dilated PT,
we used fluorescent LTA (green) and fluorescent Phalloidin
(Red), which binds F-actin in the brush border. The presence
of a brush border and apical LTA signal was used as a proxy
for differentiation. Female mice inbred on the BALBc/J
background that developed cystic changes at 3 months
clearly showed an attenuation of the brush border and
an enhancement of the LTA staining, which appeared
to be cytoplasmic and apical as opposed to purely apical
Table 1 | Number of outbred animals used for phenotypic
evaluation
Age (months) Wild type Pkhd1del2/del2
1 26 46
3 15 39
6 8 25
9 15 34
12 6 19
15 2 8
18 2 5
10a
b
9
Del2/Del2 Wild type
Del2/Del2 Wild type
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0
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Figure 2 | Liver weight and kidney weight ratios in wild-type and
Pkhd1del2/del2 animals. (a) Liver weight and (b) kidney weight to
body weight ratios compared to WT controls at 9, 12, 15, and
18 months of age. We processed a total of 159 Pkhd1del2/del2 livers
and 70 normal livers. The liver weight body ratio became significantly
larger than WT at 9 months at the Po0.05 level (n¼ 24 Pkhd1del2/del2
n¼ 11 WT), and at the Po0.01 level after 12 months (n¼ 19
Pkhd1del2/del2 n¼ 10 WT), 15 month (n¼ 8 Pkhd1del2/del2 n¼ 2 WT)
and 18 months (n¼ 5 Pkhd1del2/del2 n¼ 2 WT). Kidney weight body
ratio was never significantly different.
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(Figure 6a, b, d, e, g, and h). Outbred male mice had a
normal brush border and did not become cystic up to the age
of 15 months (Figure 6c, f, and i), implying strong resistance
to PT disease. In females of these ages, all the S3 segments
were dilated as observed by LTA staining.
Primary ciliary structure in Pkhd1 knockout animals:
Ciliary morphology was assessed by scanning electron
microscopy (SEM), as there are conflicting reports about
ciliary morphology in models of ARPKD.20,22 SEMs on cystic
liver showed that the primary cilia in the affected biliary tree
were shorter 0.8270.37 mm (n¼ 112) versus WT cilia length
2.9370.86 mm (n¼ 46, Po0.0001) (Figure 7a and b). The
cilia were often misshapen with multiple blebs (Figure 7b
insert). Transmission Electron Microscopy (TEM) of primary
cilia in the biliary tree showed that they were always
surrounded by clumps of small 50–80 nm vesicular structures
(Figure 7e and f).
In the kidney, cilia were seen above the PT brush border
(Figure 7c and d). In 9 months old female animals, surface
Figure 3 | Pkhd1del2/del2 liver and pancreas gross appearance and Mallory trichrome stained sections. (a) Gross appearance of 11 months
outbred Pkhd1del2/del2 liver. (b–g) Sections stained with Mallory trichome, (b) 1, (c) 3, (d) 6, (e) 9, (f) 12 (g) 15 months. The livers become more
cystic and fibrotic with age. (h) Severely affected grossly cystic pancreas 16 days mouse. (i) Trichrome-stained section of 16 days severely
affected cystic pancreas. (j) and (k) Hematoxylin and eosin- stained pancreas of mildly affected 9-month-old Pkhd1del2/del2 animals, note
the thickened and enlarged pancreatic ducts versus (l) the 9 month WT animal. Original magnification of (b–g) and (i–l) is  10.
Table 2 | Number of grossly cystic pancreas observed in Pkhd1del2/del2 animals
Age (months) 1 3 6 9 12 15 18
Pkhd1del2/del2 1 3 3 3 1 0 0
Percent of total 2.2 7.7 12.0 8.8 5.3 0 0
Pkhd1, polycystic kidney and hepatic disease.
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blebs, not present on normal cilia, were observed and some
cilia appeared as branched clumps (Figure 7d). We confirmed
that these ‘star burst’ structures were cilia by staining frozen
sections with anti-acetylated tubulin (Figure 7g and h). In
animals with more advanced cystic disease (15 months),
the cilia from cyst lining epithelia were usually stunted
and highly branched or ‘star-burst’. The cilia in the CD of
affected and WT female mice were not different in length
9 months
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Figure 4 | Mouse Pkhd1del2/del2 kidney sections stained with hematoxylin eosin. Kidneys from Pkhd1del2/del2 male mice at ages
(a) 9, (b) 12, and (c) 15 months, respectively (original magnification  4). (d, e, and f) Kidneys from Pkhd1del2/del2 female mice at ages (d) 9,
(e) 12, and (f) 15 months, respectively (original magnification  4). (g, h, and i) are high power views of the same female kidneys (original
magnification  10). (j, k and l) Low-power views of wildtype female kidneys at (j) 9, (k) 12, and (l) 15 months (original magnification 4).
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Figure 5 | Mouse Pkhd1del2/del2 and wild-type kidney sections stained with LTA and DBA. (a and d) WT kidney stained with the PT maker
LTA, (b and e) 15 months female Pkhd1del2/del2 kidney stained with LTA, PT marker (c and f) 15 months female Pkhd1del2/del2 kidney stained
with DBA, CD marker. (a, b, and c) low power 4 , (d, e, and f) high power 40 .
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(1.4770.40 mm, n¼ 39, and 1.5570.48 mm, n¼ 41, respec-
tively) and appeared normal (not shown). Therefore, cilia are
abnormal in the PT and biliary tree but not in the CD in this
model of ARPKD.
DISCUSSION
We generated a mouse model of ARPKD by targeting exon 2,
the first coding exon of the Pkhd1 gene. This removes the
start codon and the signal peptide from the open reading
frame of the cDNA. Analysis of 50 RACE products and
directed PCR shows that exon 2 is skipped and no possible
alternative start site was detected, indicating that Pkhd1del2
cannot make full-length FC. Western analysis with both
rabbit anti-mouse FC and chicken anti-mouse FC affinity
purified antibodies failed to detect FC in the WT kidney
membrane preparation, so we have not been able to verify
loss of the protein in the knockout mice. We are now
generating an animal with an epitope-tagged form of FC to
overcome this important problem.
Table 3 | Number of outbred animals where dilated proximal
tubules were observed
Genotype Total Dilated % Dilated
Wild type (9 months) 6 0 0
Wild type (12 months) 6 0 0
Wild type (15 months) 2 0 0
Wild type (18 months) 2 0 0
Pkhd1del2/del2 (9 months, male) 8 0 0
Pkhd1del2/del2 (9 months, female) 10 7 70
Pkhd1del2/del2 (12 months, male) 7 0 0
Pkhd1del2/del2 (12 months, female) 11 10 91
Pkhd1del2/del2 (15 months, male) 4 0 0
Pkhd1del2/del2 (15 months, female) 6 6 100
Pkhd1del2/del2 (18 months, male) 2 0 0
Pkhd1del2/del2 (18 months, female) 3 3 100
Table 4 | Tubule diameter measurements
Animal
Age
(months) Genotype
Diametera (s.d.)
(lm)
No. of
tubules
1 9 WT 29.51 (9.12) 106
2 9 WT 26.99 (6.69) 140
3 9 WT 25.71 (8.18) 112
Average 27.34 (8.06)*w 358
4 9 Pkhd1del2/del2 38.78 (11.89) 109
5 9 Pkhd1del2/del2 51.07 (13.63) 75
6 9 Pkhd1del2/del2 53.35 (12.70) 91
Average 46.98 (14.27)w** 276
7 12 WT 30.60 (8.61) 133
8 12 WT 26.30 (8.54) 104
9 12 WT 32.07 (8.30) 131
Average 29.91 (8.78)*z 368
10 12 Pkhd1del2/del2 51.23 (18.67) 147
11 12 Pkhd1del2/del2 64.95 (16.03) 133
12 12 Pkhd1del2/del2 58.56 (18.00) 181
Average 58.19 (18.26)z** 461
WT, wild type
*Po0.05; **Po0.0005; wPo0.0001; zPo0.00001.
aValues with the same symbol are significantly different. Only the group averages
were tested.
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Figure 6 | Fluorescent histochemistry of WT and Pkhd1del2/del2 animals stained with phalloidin (PHA) (red), LTA (green), and
DAPI (blue). (a, d, and g) Three month normal female, (b, e, and h) 3 month Pkhd1del2/del2 female inbred, F 10, BALBc/J background,
(c, f, and i) 15 month Pkhd1del2/del2 male. PHA binds to F-actin of the brush border in the PT. Loss of PHA staining is evident in the dilated
proximal S3 segments in the Pkhd1del2/del2 animals (indicated by yellow arrowheads) similar to the loss, and disorganized pattern, of periodic
acid shift staining (data not shown). PHA staining is present in S3 tubules that are not dilated in WT and Pkhd1del2/del2 animals
(indicated by white arrowheads). This shows that differentiation and polarity are maintained in the PT until very late in the male’s life.
(Original magnification  40).
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The Pkhd1del2/del2 mouse is a faithful model of the
fibrocystic liver disease associated with human ARPKD.
The hepatic phenotype of Pkhd1del2/del2 is similar to the other
rodent models with mutations in Pkhd1, the ex40 mouse and
PCK rat. The disease starts at 1 m of age with the
development of tortuous bile ducts and enlargement of the
portal triads. At between 3 and 9 months both portal
fibrosis and cystogenesis become more prominent so that by
12–15 months the liver is very cystic and fibrotic.
The pancreatic disease is an important feature of the
Pkhd1del2/del2 mouse with histologically evident cysts budding
from the pancreatic duct by 6 month of age in 48% of the
animals. The aggressive pancreatic disease appears to be a
unique feature of the model, which has not been observed in
the PCK or ex40 mouse. This severe phenotype only occurred
in animals with a significant 129Sve contribution and as we
inbred the animals it has become rarer. This could be because
129Sve modifier genes are important in the generation of this
phenotype. There is one report of a series of nine human
patients with ARPKD, six of whom were known to have
pancreatic fibrosis, probably secondary to cystogenesis.23
We observed an unexpected and novel renal phenotype
consisting of PT dilatation in female homozygotes; male
homozygotes appear to be protected from PT dilatation.
Inbreeding onto either the BALBc/J or C57BL/6J back-
grounds exacerbates the kidney disease so that all females
develop PT cysts by 3 months.
The kidney phenotype in the Pkhd1del2/del2 mouse is
different from the two other animal models of rodent
ARPKD as the animals develop PT cysts in adulthood. The
ex40 mouse never develops renal tubular dilatation up to 14
months of age,20 whereas the PCK rat develops cysts in the
CD and the distal tubule.19 However, PT dilatation is a
feature of early ARPKD in the human fetus and at least two
models of mouse polycystic kidney disease with defects in
ciliary proteins. These models, orpk (IFT88)5 and cpk
(cystin)6,24 mice, have a transient phase of PT dilatation,
which has been studied in the cpk mouse. In the cpk mouse,
81% of the PTs are cystic at birth but by 3 weeks of age; there
is a significant decrease in the number of dilated PTs with
only 31% of PT dilated, whereas all CDs are dilated.5 In the
early ARPKD fetus, PT dilatation is approximately as
common as CT dilatation but after 34 weeks of gestation
the CT disease predominates and there is no visible PT
disease. This regression of PT dilatation and subsequent shift
to CD dilatation does not appear to occur in the Pkhd1del2/
del2 mouse implying that it may be a stalled form of ARPKD.
One important aspect of this animal model is that the
renal disease is restricted to the female and the male appears
to be protected. This is unusual as there are several models of
polycystic kidney disease in which the males are more
severely affected than the females, such as the jck mouse25
and the Han:SPRD, Cy/þ rat.26,27 Male patients appear to
have more severe disease in PKD228 and perhaps PKD1.29
The sex difference in renal disease in mice could be due to
sexual dimorphism in the S3 segment of the PT. In the male,
the S3 segment has larger and more electron lucent
mitochondria and more and larger lysosomes than the
female; a feature controlled by androgens.30 This segment of
the nephron secretes lysosomal enzymes, a function better
developed in males and also under the control of androgens.
Females have a more prominent brush than males.31,32 These
hormonal effects on PT morphology raise the possibility that
the PT disease seen in the human fetus with ARPKD and in
embryos of many rodent models of ARPKD could be driven
by the high circulating levels of maternal estrogen. This
would be consistent with development of PT cysts restricted
to females and at a later age in our model of ARPKD.
There is debate over whether there is a primary cilia defect
in animals with mutations in Pkhd1. Moser et al. showed by
TEM that the cilia were normal in ex40 mice. However, TEM
10 m 2 m
0.5 m0.5 m
e f
c d
a b
g h
5 m 5 m
Figure 7 | Primary cilia in bile duct and PT by SEM and fluorescent
histochemistry. (a) A normal bile duct with normal cilia from
a WT animal 3 months of age. (b) Three month biliary tree from a
Pkhd1del2/del2 animal showing shorter and malformed cilia, see inset.
(c and d) In the PT the brush border is still visible in these early
dilatations (9 month Pkhd1del2/del2 animals) but appears disorganized.
The cilia at this early stage are ‘starburst’ (arrows in c and d). This
implies gross cilial dysfunction in these animals. Inset shows a
branched primary cilium. (e and f) TEM of WT biliary cilia (e) and
Pkhd1del2/del2 biliary cilia (f) note the small vesicular structures around
the cilium. (g and h) Staining of PT cilia by anti-acetylated tubulin
(green) and nuclei by DAPI (blue) in the WT (g) and Pkhd1del2/del2
(h). Note the ‘starburst’, highly branched cilia in H (arrow). (g–h,
Original magnification  40).
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is probably not the best tool to study ciliary morphology as
the entire length of the cilium is rarely visualized. We used
SEM and showed that, in the bile ducts of 3-month-old mice,
the cilia are shorter and have multiple blebs on their surface.
In the early PT cysts in the female (9 months), cilia with
multiple blebs and in some cases branched morphologies are
seen penetrating the brush border. In other cysts of the same
age, cilia are difficult to visualize possibly because they are
small and hidden in the brush border.
TEM showed that the biliary cilia were always surrounded
by clumps of vesicular structures of 50–80 nm in diameter
of unknown origin. They may be fragments of ciliary
plasma membrane that are being shed from the cilium
itself or vesicles similar to ‘nodal vesicular parcels’33 thought
to interact with the primary cilium in the embryonic
node.
In summary the Pkhd1del2/del2, mouse model of ARPKD
develops both cystic liver and pancreatic disease in both
sexes. The PT dilation in the kidney is only seen in the
female mouse relatively late in the animals life, 9 months in
the outbred background and around 3 months in the inbred
lines. The proximal dilatation seen in these animals may
mimic the very early stages of human ARPKD making the
Pkhd1del2/del2 mouse a useful tool for dissecting out the role of
sex hormones and genetic background in the initiation of the
disease state.
MATERIALS AND METHODS
Constructing the Pkhd1 knockout
All animal experiments were conducted under protocols approved
by the Mayo Institutional Animal Care and Use Committee
(IACUC). The knockout construct contains genomic DNA from
3.9 kb 50 to the start codon of exon 2 to 2.2 kb 30 to exon 4. A
conventional loxP flanked PGK neomycin cassette replaced exon 2
and at the 50 end there is a PGK-thymidine kinase cassette for
negative selection (Figure 1a). Embyronic stem cell targeting and
chimera production were performed with a standard protocol.34 To
remove the germline floxed neomycin cassette, heterozygous mice,
Pkhd1neo2/þ , were crossed to mice transgenic for mouse mammary
tumor virus-Cre.21 We inbred both Pkhd1neo2 and Pkhd1del2 mice on
a BALBc/J and C57BL/6J background to generation 10.
PCR assays
A multiplex PCR assay was developed to genotype the animals. The
WT product is 1028 bp, the Pkhd1neo2 is 794 bp and the Cre
recombined Pkhd1del2 is 900 bp. Three primers were used: F1 50-
GGACCTTACAATCTTTTTGCCCC-30, R1 50-GCTTCCTCGTGCT
TTACGGTATC-30 and R2 50-CATCATACAGTTCTCAGACCCCG-30.
The reaction conditions were 30 cycles of 30 s at 941C (denaturing),
30 s at 561C (annealing) and 90 s at 721C (extension) using a
QIAGENs (Valencia, CA, USA) multiplex PCR kit mix.
Reverse transcription-PCR was carried out on total cellular RNA
from liver and kidney that has reverse transcribed and amplified
with an exon 1 primer 50-CGGCTTCGTTTAGAAGGGGAC-30 and
an exon 7 primer 50-TCCAGCCAGGTAGTGATGACCC-30. The
reaction conditions were 35 cycles of 60 s 941C, 30 s 581C, and 60 s
of 721C, using Taq polymerase (AmpliTaq Gold) Perkin Elmer
(Wellesley, MA, USA).
Histology
Animals were euthanized and the organs dissected, weighed, and fixed
in 4% paraformaldehyde. Tissues were then embedded in parafin and
5mm sections cut from each tissue. Hematoxylin/eosin and Mallory
trichrome staining was performed according to standard procedures
by the Mayo Clinic Histology laboratory. Kidney tubules were
measured using MetaMorph software package version 6.3r7 (Mole-
cular Devices, Downingtown, PA, USA). Number of tubules,
measured from basement lamina to basement lamina, ranged from
75 to 181 from female kidneys at 9 and 12 months of age and from
both WT and Pkhd1del2/del2 genotypes. Student’s t-test was performed
to test differences between age-genotype groups.
Electron microscopy
SEM of liver and kidney tissue employed the protocol of Masyuk
et al.35 Briefly, liver or kidney tissue was fixed in 4% paraformalde-
hyde/2% glutaraldehyde for 2 h, incubated in 1% osmium tetroxide
for 30 min, dehydrated, dried in a critical point drying device and
mounted. SEM was performed with a Hitachi S-4700 microscope.
For TEM, samples were postfixed in 1% osmium tetroxide for 1 h,
dehydrated, embedded in Spurrs resin, sectioned at 80 nm, and
visualized with a Joel 1200 electron microscope.
Immunofluorescence
Mice were anesthetized with 50 mg/kg sodium pentobarbital. The
left ventricle was cannulated and the inferior vena cava cut. The
mice were perfused with phosphate-buffered saline (PBS) followed
by a similar volume of 4% paraformaldehyde in PBS. Finally, the
animals were perfused with 10% sucrose/20 mM N-2-hydroxyethyl-
piperazine-N0-2-ethanesulfonic acid (pH 7.2). Kidney, liver, pan-
creas, and gall bladder were removed, embedded in Optimum
Cutting Temperature (OCT), snap frozen in liquid nitrogen cooled
methyl butane and then stored at 801C until use. Five micron
sections were taken mounted on positively charged slides and dried
for 20 min at 601C. For LTA36 or DBA36,37 (Vector Laboratories,
Burlingame, CA, USA) staining, biotinylated LTA or DBA was
applied at 5 mg/ml in 1% bovine serum albumin PBS (30 min; 201C),
to sections permeabilized with 0.1% Triton-X in PBS. Slides were
washed three times in PBS then detected with 5 mg/ml Alexa Fluors
488 labeled streptavidin (Invitrogen, Carlsbad, CA, USA) for 20 min
and 100 nM Alexa Fluors Phalloidin 594 (Invitrogen). Slides were
washed with PBS three times then exposed to 3 mM 40-diamidino-2-
phenylindole (DAPI) for 1 min, washed then mounted with vector
shield (Vector Laboratories). Kidney morphology was accessed by a
trained, blinded pathologist (DL).
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